Syncom Formulations (India) Ltd.
| BSE: 524470 |
Sector: Health care |
| NSE: SYNCOMF |
ISIN Code: INE312C01025 |
|
BSE
15:24 | 24 Mar
|
6.00
|
0.01
(0.17%)
|
OPEN
5.82
|
HIGH
6.06
|
LOW
5.82
|
|
NSE
15:09 | 24 Mar
|
5.95
|
-0.05
(-0.83%)
|
OPEN
6.00
|
HIGH
6.10
|
LOW
5.85
|
| OPEN |
5.82 |
| PREVIOUS CLOSE |
5.99 |
| VOLUME |
270450 |
| 52-Week high |
13.00 |
| 52-Week low |
5.82 |
| P/E |
35.29 |
| Mkt Cap.(Rs cr) |
564 |
| Buy Price |
5.94 |
| Buy Qty |
878.00 |
| Sell Price |
6.00 |
| Sell Qty |
49067.00 |
| OPEN |
6.00 |
| PREVIOUS CLOSE |
6.00 |
| VOLUME |
790607 |
| 52-Week high |
11.60 |
| 52-Week low |
5.80 |
| P/E |
35.29 |
| Mkt Cap.(Rs cr) |
564 |
| Buy Price |
5.95 |
| Buy Qty |
2924.00 |
| Sell Price |
6.00 |
| Sell Qty |
46677.00 |
| OPEN |
5.82 |
| CLOSE |
5.99 |
| VOLUME |
270450 |
| 52-Week high |
13.00 |
| 52-Week low |
5.82 |
| P/E |
35.29 |
| Mkt Cap.(Rs cr) |
564 |
| Buy Price |
5.94 |
| Buy Qty |
878.00 |
| Sell Price |
6.00 |
| Sell Qty |
49067.00 |
| OPEN |
6.00 |
| PREVIOUS CLOSE |
6.00 |
| VOLUME |
790607 |
| 52-Week high |
11.60 |
| 52-Week low |
5.80 |
| P/E |
35.29 |
| Mkt Cap.(Rs cr) |
564.00 |
| Buy Price |
5.95 |
| Buy Qty |
2924.00 |
| Sell Price |
6.00 |
| Sell Qty |
46677.00 |
Syncom Formulations (India) Ltd. (SYNCOMFORMUL) - Company Information
Syncom Formulations (India) Ltd
Incorporated as a private limited company in 1988 Syncom Formulations (India) was converted into a public limited company in Jun.'92. The company set up a manufacturing facility at Palghar Thane to produce pharmaceutical formulations. Commercial production commenced in Apr.'89. Promoters are Kedarmal Bankda Vijay Kumar Bankda and Ajay Kumar Bankda.In addition to pharmaceutical formulations in the ...> More
| COMPANY INFORMATION |
| Chairman & Wholetime Director : |
Kedarmal Bankda |
| Managing Director : |
Vijay Shankarlal Bankda |
| Independent Director : |
Vinod Kumar Kabra |
| Independent Director : |
Krishna Das Neema |
| Independent Director : |
Praveen Jindal |
| Whole-time Director : |
Rinki Bankda |
| Company Secretary : |
Prachi Jain |
| Additional Director : |
Ruchi Jindal |
| AUDITOR : |
Sanjay Mehta & Associates |
| IND NAME : |
Pharmaceuticals - Indian - Formulations |
| HOUSE NAME : |
Indian Private |
| Registered office |
| 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd,Mumbai,Maharashtra-400093 |
| Ph : 91-22-30887744 |
| WEBSITE : http://www.sfil.in |
| E-mail : info@sfil.in / finance@sfil.in |
Quick Links for Syncom Formulations (India):
